Ocumension Therapeutics
HKEX:1477

Watchlist Manager
Ocumension Therapeutics Logo
Ocumension Therapeutics
HKEX:1477
Watchlist
Price: 5.08 HKD -3.97% Market Closed
Market Cap: 4.1B HKD
Have any thoughts about
Ocumension Therapeutics?
Write Note

Ocumension Therapeutics
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ocumension Therapeutics
Cash from Financing Activities Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Ocumension Therapeutics
HKEX:1477
Cash from Financing Activities
ÂĄ108.7m
CAGR 3-Years
-59%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cash from Financing Activities
-ÂĄ753.7m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cash from Financing Activities
-ÂĄ2.1B
CAGR 3-Years
-52%
CAGR 5-Years
-54%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cash from Financing Activities
-ÂĄ661.2m
CAGR 3-Years
N/A
CAGR 5-Years
4%
CAGR 10-Years
-32%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cash from Financing Activities
-ÂĄ3B
CAGR 3-Years
15%
CAGR 5-Years
20%
CAGR 10-Years
-19%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cash from Financing Activities
ÂĄ90.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ocumension Therapeutics's Cash from Financing Activities?
Cash from Financing Activities
108.7m CNY

Based on the financial report for Dec 31, 2023, Ocumension Therapeutics's Cash from Financing Activities amounts to 108.7m CNY.

What is Ocumension Therapeutics's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-5%

The average annual Cash from Financing Activities growth rates for Ocumension Therapeutics have been -59% over the past three years , -5% over the past five years .

Back to Top